Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-14T06:19:49.495Z Has data issue: false hasContentIssue false
  • English
  • Français

Depot risperidone in elderly patients: the experience of an Australian aged psychiatry service

Published online by Cambridge University Press:  05 July 2007

DHIREN SINGH  and
DANIEL W. O'CONNOR
DHIREN SINGH
Affiliation:
Department of Psychological Medicine, Monash University, and Southern Health, Melbourne, Australia Email: dhiren.singh@southernhealth.org.au
DANIEL W. O'CONNOR
Affiliation:
Department of Psychological Medicine, Monash University, and Southern Health, Melbourne, Australia Email: dhiren.singh@southernhealth.org.au
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Antipsychotic medications form the mainstay of both the acute and maintenance treatment of schizophrenia. In recent years, atypical antipsychotics like risperidone, olanzapine and clozapine have come to be preferred because of their lower incidence of extra-pyramidal, anti-cholinergic and cardiac side-effects and a possible greater efficacy in reducing negative and neuro-cognitive symptoms (Ritchie et al., 2006).

Type
Letter
Information
International Psychogeriatrics , Volume 19 , Issue 4 , August 2007 , pp. 789 - 792
Copyright
International Psychogeriatric Association 2007